Edition:
United Kingdom

DelMar Pharmaceuticals Inc (DMPI.OQ)

DMPI.OQ on NASDAQ Stock Exchange Capital Market

0.57USD
12 Nov 2018
Change (% chg)

$-0.03 (-4.98%)
Prev Close
$0.60
Open
$0.56
Day's High
$0.58
Day's Low
$0.56
Volume
1,966
Avg. Vol
17,006
52-wk High
$1.81
52-wk Low
$0.36

Chart for

About

DelMar Pharmaceuticals, Inc. is a clinical-stage drug development company. The Company focuses on the treatment of cancer. The Company is engaged in conducting clinical trials in the United States with its product candidate, VAL-083, as a treatment for glioblastoma multiforme (GBM), a form of brain cancer. VAL-083 is being... (more)
No analyst recommendations are available for .

Overall

Beta: 1.79
Market Cap(Mil.): $12.91
Shares Outstanding(Mil.): 22.41
Dividend: --
Yield (%): --

Financials

  DMPI.OQ Industry Sector
P/E (TTM): -- 9.36 17.53
EPS (TTM): -0.56 -- --
ROI: -184.98 7.61 0.44
ROE: -- 9.70 16.27

Earnings vs. Estimates